Lipid
profiler
(continued)
Most
cancer deaths are caused by metastasis. Cut off the tumor's food
source, keep it from metastasizing, and you have a disease that
is local and manageable instead of the nation's second-leading killer.
"If
we could reduce the incidence of breast cancer metastasis, it would
be a much more treatable disease," says Erickson, "especially
since fewer than 10 percent of all cases of breast cancer have metastasized
at the time of early diagnosis."
Erickson
further believes that the metabolites of conjugated linoleic acid
reduce the body's production of prostaglandins, a tumor-promoting,
hormone-like substance which can also suppress the immune system
and hence, alter the transmission of cellular events that cause
cancer.
That's
not to say you should make triple cheeseburgers a regular part of
your diet. In the foods that have it, conjugated linoleic acid is
found only in small amounts. Supplementation seems a better way
to go, and no one is sure how much to take, how it works in people,
or whether conjugated linoleic acid in food will do the trick. It
may, Erickson hypothesizes, some day be considered a supplemental
therapy for breast cancer or other-fat sensitive cancers such as
colon and prostate cancer.
Human
cancer trials of this intriguing lipid could start in a few years,
once Erickson's current project is finished and a human study done
in collaboration with the U.S. Department of Agriculture Metabolic
Research Unit in San Francisco is completed.
In
that study, Agriculture Department scientists analyzed the diet
of volunteers who lived for 120 days in a special metabolic research
facility. They stayed there 24 hours a day, seven days a week, for
the duration of the experiment. The volunteers were analyzed under
strict laboratory conditions. "It's not like a free-living
study, where you give people supplements to take but you have no
way of knowing if they did what they were supposed to," says
Erickson.
Not
surprisingly, healthy volunteers for this kind of 24-hour-a-day
study are difficult to come by, and drop-out rates are high. Still,
information from a dozen women volunteers who received conjugated
linoleic acid in their food as part of the experiment in 1998 is
waiting to be analyzed.
Meanwhile,
in Erickson's biology laboratory, mice injected with breast tumor
cells nibble their special diets of grains and conjugated linoleic
acid, a whitish substance that in mice-meal looks like parmesan
cheese. What will be the results? Fat-lovers of the world await.
Home |
Table of Contents |
To our Readers |
Building on Basics
Focusing on Patients |
In Translation |
First Steps
Campus Connection |
Benefactors |
News in Brief
UC Davis Health System |
© 2000, 2001, 2002 UC Regents. All rights reserved.
|